SCHEMBL1870772

SCHEMBL1870772

[c]1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
MAPK1 P28482 1/20 0.50
ADORA2A P29274 4/20 0.46
ADORA1 P30542 4/20 0.46
ADORA3 P0DMS8 3/20 0.46
ADORA2B P29275 3/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR1H2 P55055 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5909638 0.84 MEN1 (0.44) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL29106027 0.84 MEN1 (0.41) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL7720117 0.84 NPC1 (0.41) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL6294638 0.84 L3MBTL1 (0.59) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL371042 0.80 L3MBTL1 (0.74) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL3290097 0.80 L3MBTL1 (0.39) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL4720293 0.80 MAPT (0.47) L3MBTL1RAB9ANPC1MAPK1MEN1
SCHEMBL8625654 0.80 HSP90AA1 (0.59) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL6294541 0.80 NOTUM (0.43) L3MBTL1RAB9ANPC1MAPK1ADORA2A
SCHEMBL27817224 0.80 TDP1 (0.47) L3MBTL1RAB9ANPC1MAPK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115626914-B Carbazole compound and application thereof 冠能光电材料(深圳)有限责任公司 2024-04-30 CN claimed
CN-114853725-B Organic photoelectric compound, display panel and display device 武汉天马微电子有限公司 2024-03-05 CN claimed
CN-116768907-A Organic compound, OLED device, display panel and display device 武汉天马微电子有限公司 2023-09-19 CN claimed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US claimed
CN-116082374-A Boron nitride compound, composition containing boron nitride compound and application of boron nitride compound 季华恒烨(佛山)电子材料有限公司 2023-05-09 CN claimed
US-20230108999-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-06 US claimed
US-11575090-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2023-02-07 US claimed
CN-115626914-A Carbazole compound and application thereof 冠能光电材料(深圳)有限责任公司 2023-01-20 CN claimed
EP-3790857-B1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO (JP) 2023-01-11 EP claimed
CN-114853725-A Organic photoelectric compound, display panel and display device 武汉天马微电子有限公司 2022-08-05 CN claimed
US-20150337096-A1 FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-11-26 US claimed
EP-2935373-A1 COPOLYMERS INCLUDING ULTRAVIOLET ABSORBING GROUPS AND FLUOROPOLYMER COMPOSITIONS INCLUDING THEM 3M Innovative Properties Company (US) 2015-10-28 EP claimed
EP-2935472-A1 FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP 3M Innovative Properties Company (US) 2015-10-28 EP claimed
WO-2014100551-A1 COPOLYMERS INCLUDING ULTRAVIOLET ABSORBING GROUPS AND FLUOROPOLYMER COMPOSITIONS INCLUDING THEM 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-06-26 WO claimed
WO-2014100580-A1 FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-06-26 WO claimed
US-20120211701-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-23 US claimed
WO-2011126224-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2011-10-13 WO claimed
WO-2011093609-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2011-08-04 WO claimed
WO-2011050888-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-05-05 WO claimed
US-4017483-A OPTICAL BRIGHTENERS CIBA-GEIGY CORPORATION (US) 1977-04-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 L3MBTL1 1990/4885RAB9A 2769/4885NPC1 3296/4885
US-20120211701-A1 MATERIALS FOR ELECTRONIC DEVICES XPOT, ETV6, ERCC1 L3MBTL1 3516/4885RAB9A 1691/4885NPC1 2092/4885
US-11575090-B2 Organic compound and organic electroluminescence device using the same OR10J3, PIEZO1, ODC1 L3MBTL1 1538/4885RAB9A 3321/4885NPC1 746/4885
US-20230108999-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR10J3, RER1, L1CAM L3MBTL1 298/4885RAB9A 1512/4885NPC1 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.